2024-19725. Medical Devices; Dental Devices; Classification of the Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea
Table 1—Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea Risks and Mitigation Measures
Identified risks to health Mitigation measures Adverse tissue reaction Biocompatibility evaluation. Interference with other devices/electrical shock Electrical safety testing, Electromagnetic compatibility (EMC) testing, Battery safety testing, Wireless coexistence testing, and Labeling. Use error leading to pain, discomfort, or injury Human factors assessment; Software verification, validation, and hazard analysis; Electrical safety testing; and Labeling. Mucosal or skin overheating or burn Software validation, verification, hazard analysis; Electrical safety testing; Electromagnetic compatibility (EMC) testing; and Labeling. Infection Labeling.
Document Information
- Effective Date:
- 9/3/2024
- Published:
- 09/03/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final amendment; final order.
- Document Number:
- 2024-19725
- Dates:
- This order is effective September 3, 2024. The classification was applicable on February 5, 2021.
- Pages:
- 71153-71155 (3 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-3948
- Topics:
- Medical devices
- PDF File:
- 2024-19725.pdf
- CFR: (1)
- 21 CFR 872